Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease

Journal of Clinical Investigation

Volumn 108, Issue 12, 2001, Pages 1833-1841

  Choi, Sun Jin ^a   Oba, Yasuo ^a   Gazitt, Yair ^a   Alsina, Melissa ^b   Cruz, Jose ^c   Anderson, Judith ^d   David Roodman, G ^a,d,e  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e Research (151) E 1152 BST   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BONE DESTRUCTION; BONE DISEASE; CELL ADHESION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MORPHOMETRICS; MOUSE; MULTIPLE MYELOMA; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD18; ANTIGENS, CD29; ANTISENSE ELEMENTS (GENETICS); BONE DISEASES; HUMANS; INTEGRIN ALPHA5; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, SCID; MULTIPLE MYELOMA; OSTEOCLASTS;

EID: 0035664488     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200113116     Document Type: Article

References (22)

1. Development of an in vivo model of human multiple myeloma bone disease
2. Macrophage inflammatory protein 1-alpha (MIP-1α) is a potential osteoclast stimulatory factor in multiple myeloma
3. Macrophage inflammatory protein 1-alpha is an osteoclastogenic factor in myeloma that is independent of RANK ligand
4. Macrophage inflammatory protein-1α (LD78) expressed in human bone marrow: Its role in regulation of hematopoiesis and osteoclast recruitment
5. Macrophage inflammatory protein-1-alpha and IL-18 stimulate the motility but suppress the resorption of isolated rat osteoclasts
6. Structures of human genes coding for cytokine LD78 and their expression
7. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines
8. Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption
9. Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term human marrow cultures
10. Expression of adhesion molecules on CD34+ cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors
11. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway
12. Regulation of monocyte integrin expression by beta-family chemokines
13. 1 integrin enhances production of osteoclast-stimulating activity
14. Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-β1-treated bone marrow stroma
15. Macrophage inflammatory protein (MIP)-1α stimulates osteoclast formation and bone resorption in vivo
16. Production of MIP-1α by human myeloma cells and its clinical significance
17. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines
18. Adhesion to fibronectin via beral integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAMDR)
19. Interleukin-6: A potential autocrine/pasacrine factor in Paget's disease of bone
20. The proliferative potential of myeloma plasma cells manifest in the SCID-Hu host
21. Advances in therapy of multiple myeloma: Lessons from acute leukemia
22. Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity